Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.15537/smj.2021.1.25588 http://scihub22266oqcxt.onion/10.15537/smj.2021.1.25588 33399169!7989313!33399169     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Saudi+Med+J 2021 ; 42 (1): 38-43 Nephropedia Template TP {{tp|p=33399169|t=2021. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia |pdf=|usr=}}{{33399169}} gab.com Text Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia JO: Saudi Med J http://www.kidney.de/pget.php?&tw=1&pmid=33399169 #FOAvip OBJECTIVES: To assess the prevalence of anosmia in coronavirus-19 (COVID-19) patients. Coronavirus-19-related anosmia and hyposmia is a new emerging concept in the medical literature. METHODS: A retrospective study on COVID-19 patients with anosmia and hyposmia was performed during the period between May-July, 2020. The inclusion criteria were all clinically stable COVID-19 patients less than 15 years old with positive reverse transcription-polymerase chain reaction (RT-PCR). Patients who refused to participate or leave incomplete questions were excluded. In this study, we investigated 1022 patients who met our criteria. RESULTS: Olfactory dysfunction (OD) was reported by 53% of our COVID-19 patients, of which 32.7% were anosmic and 20.3% were hyposmic. Other neurological symptoms included ageusia (51.4%), fatigue (63%), myalgia (59.2%), and headache (50.9%), all of which showed significant association with OD. In addition, anosmia had a significant association with young age and female gender. However, there was no association between OD and pre-existing neurological disease. CONCLUSION: Half of our COVID-19 patients presented OD (anosmia/hyposmia), which often associated with ageusia and many neurological symptoms. Twit Text FOAVip Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia ????Saudi Med J http://www.kidney.de/pget.php?&tw=1&pmid=33399169 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33399169 #FOAvip English Wikipedia <ref>{{Cite pmid|33399169}}</ref> Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia #MMPMID33399169 Mubaraki AA; Alrbaiai GT; Sibyani AK; Alhulayfi RM; Alzaidi RS; Almalki HS Saudi Med J 2021[Jan]; 42 (1): 38-43 PMID33399169show ga OBJECTIVES: To assess the prevalence of anosmia in coronavirus-19 (COVID-19) patients. Coronavirus-19-related anosmia and hyposmia is a new emerging concept in the medical literature. METHODS: A retrospective study on COVID-19 patients with anosmia and hyposmia was performed during the period between May-July, 2020. The inclusion criteria were all clinically stable COVID-19 patients less than 15 years old with positive reverse transcription-polymerase chain reaction (RT-PCR). Patients who refused to participate or leave incomplete questions were excluded. In this study, we investigated 1022 patients who met our criteria. RESULTS: Olfactory dysfunction (OD) was reported by 53% of our COVID-19 patients, of which 32.7% were anosmic and 20.3% were hyposmic. Other neurological symptoms included ageusia (51.4%), fatigue (63%), myalgia (59.2%), and headache (50.9%), all of which showed significant association with OD. In addition, anosmia had a significant association with young age and female gender. However, there was no association between OD and pre-existing neurological disease. CONCLUSION: Half of our COVID-19 patients presented OD (anosmia/hyposmia), which often associated with ageusia and many neurological symptoms. |Adolescent[MESH] |Adult[MESH] |Age Factors[MESH] |Ageusia/virology[MESH] |Anosmia/*epidemiology/*virology[MESH] |COVID-19 Nucleic Acid Testing[MESH] |COVID-19/*complications/diagnosis[MESH] |Fatigue/virology[MESH] |Headache/virology[MESH] |Humans[MESH] |Middle Aged[MESH] |Myalgia/virology[MESH] |Prevalence[MESH] |Retrospective Studies[MESH] |Reverse Transcriptase Polymerase Chain Reaction[MESH] |SARS-CoV-2[MESH] |Saudi Arabia/epidemiology[MESH] |Sex Factors[MESH]Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of(epmc).pdf DeepDyve Pubget Overpricing